Drug Type Small molecule drug |
Synonyms KAT 101, KAT101 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrolamellar Hepatocellular Carcinoma | Phase 2 | KR | 01 Nov 2022 |